Journal
CLINICAL INFECTIOUS DISEASES
Volume 48, Issue 7, Pages 988-991Publisher
UNIV CHICAGO PRESS
DOI: 10.1086/597353
Keywords
-
Categories
Funding
- Ministry of Health
Ask authors/readers for more resources
Two hundred thirty-seven Ghanaian human immunodeficiency virus-infected patients who were starting antiretroviral therapy underwent clinical and immunological monitoring for 3 years. Seventy-eight percent of patients had disease classified as World Health Organization stage III or IV. The mean increase in the CD4 cell count was 395 cells/mm(3), 13% of patients experienced immunological failure, and 8% of patients switched treatment to a second-line regimen. However, two-thirds of patients who experienced immunological failure did not switch treatment, and 31% of all patients were lost to follow-up.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available